Item 9A. Controls and Procedures
ITEM 9A. CONTROLS AND PROCEDURES
Evaluation of Our Disclosure Controls and Procedures
Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Annual Report on Form 10-K.
Based on management’s evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended. Under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2021 based on the guidelines established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Our internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.
Based on the results of our evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2021. We reviewed the results of management’s assessment with our Audit Committee.
Ernst & Young LLP, our independent registered public accounting firm, has issued a report on the Company’s internal control over financial reporting as of December 31, 2021, which is presented below.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the three months ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
Our management, including our chief executive officer and chief financial officer, believes that our disclosure controls and our internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
134
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors of eHealth, Inc.
Opinion on Internal Control over Financial Reporting
We have audited eHealth, Inc.’s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, eHealth, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2021 consolidated financial statements of the Company and our report dated March 1, 2022 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Ernst & Young LLP
Redwood City, California
March 1, 2022
ITEM 9B. OTHER INFORMATION
None.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not applicable.
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information concerning our directors, executive officers, compliance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and corporate governance required by this Item 10 of Form 10-K is incorporated by reference from the information contained in the Definitive Proxy Statement for the Annual Meeting of Stockholders, which is expected to be filed within 120 days after our fiscal year ended December 31, 2021.
We have adopted a code of ethics that applies to all employees, including our principal executive officer, Francis Soistman, principal financial officer, Christine Janofsky, and all other executive officers. The code of ethics is available on the governance page of our website at ir.ehealthinsurance.com . A copy may also be obtained without charge by contacting investor relations, attention Senior Vice President of Investor Relations, 2625 Augustine Drive, Second Floor, Santa Clara, CA, 95054 or by calling (650) 584-2700.
We plan to post on our website at the address described above any future amendments or waivers of our Code of Conduct.
ITEM 11. EXECUTIVE COMPENSATION
The information required by Item 11 of Form 10-K is incorporated herein by reference from the information contained in the Definitive Proxy Statement for the Annual Meeting of Stockholders, which is expected to be filed within 120 days after our fiscal year ended December 31, 2021.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information required by Item 12 of Form 10-K is incorporated herein by reference from the information contained in the Definitive Proxy Statement for the Annual Meeting of Stockholders, which is expected to be filed within 120 days after our fiscal year ended December 31, 2021.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by Item 13 of Form 10-K is incorporated herein by reference from the information contained in the Definitive Proxy Statement for the Annual Meeting of Stockholders, which is expected to be filed within 120 days after our fiscal year ended December 31, 2021.
136
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required by Item 14 of Form 10-K is incorporated herein by reference from the information contained in the Definitive Proxy Statement for the Annual Meeting of Stockholders, which is expected to be filed within 120 days after our fiscal year ended December 31, 2021.
137
PART IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) We have filed the following documents as part of this Annual Report on Form 10-K:
1. Consolidated Financial Statements
Information in response to this Item is included in Item 8 of Part II of this Annual Report on Form 10-K.
2. Financial Statement Schedules
All schedules are omitted because they are not applicable, not required or because the required information is included in the consolidated financial statements or notes thereto.
3. Exhibits
See Item 15(b) below.
(b) Exhibits – We have filed, or incorporated into this Annual Report on Form 10-K by reference, the exhibits listed on the accompanying Index to Exhibits of this Annual Report on Form 10‑K.
(c) Financial Statement Schedule – See Item 15(a) above.
ITEM 16. FORM 10-K SUMMARY
None.
138
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
March 1, 2022
eHealth, Inc.
/s/ FRANCIS SOISTMAN /s/ CHRISTINE JANOFSKY
Francis Soistman
Chief Executive Officer
Christine Janofsky
Chief Financial Officer
139
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on March 1, 2022.
Signature Title
/s/ FRANCIS SOISTMAN Chief Executive Officer
(Principal Executive Officer) and Director
Francis Soistman
/s/ CHRISTINE JANOFSKY Chief Financial Officer
Christine Janofsky (Principal Financial Officer and Principal Accounting Officer)
/s/ ANDREA BRIMMER Director
Andrea Brimmer
/s/ BETH A. BROOKE Director
Beth A. Brooke
/s/ A. JOHN HASS Director
A. John Hass
/s/ RANDALL S. LIVINGSTON Director
Randall S. Livingston
/s/ ERIN RUSSELL Director
Erin Russell
/s/ CESAR SORIANO Director
Cesar Soriano
/s/ AARON TOLSON Director
Aaron Tolson
/s/ DALE B. WOLF Director
Dale B. Wolf
140
EXHIBIT INDEX
Exhibit
Number Incorporation by Reference Herein
Description of Exhibit
Form Date
3.1 Amended and Restated Certificate of Incorporation of the Registrant
Registration Statement on
Form S-l, as amended
(File No. 333-133526) April 25, 2006
3.2 Amended and Restated Bylaws of the Registrant
Current Report on Form 8‑K (File No. 001-33071) December 17, 2021
3.3 Certificate of Designations of Series A Preferred Stock, par value $0.001, of eHealth, Inc.
Current Report on Form 8‑K (File No. 001-33071) May 3, 2021
4.1 Form of the Registrant’s Common Stock Certificate
Registration Statement on
Form S-l, as amended
(File No. 333-133526) June 28, 2006
4.2 † Description of Capital Stock
10.1* Form of Indemnification Agreement
Annual Report on Form 10-K
(File No. 001-33071) February 26, 2021
10.2* Employment Agreement, dated May 31, 2016, between Scott N. Flanders and eHealth, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) August 8, 2016
10.3* Employment Agreement, dated June 4, 2018, between Derek Yung and eHealth, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) August 7, 2018
10.4* Severance Agreement, dated June 5, 2020, between John Pierantoni and eHealth, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) November 8, 2021
10.5* Separation and Consulting Agreement, dated September 22, 2021, between Scott N. Flanders and eHealth, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) November 8, 2021
10.6* Employment Agreement, dated December 13, 2021, between Fran Soistman and eHealth, Inc.
Current Report on Form 8-K (File No. 001-33071) December 17, 2021
10.7* Severance Agreement, dated as of February 10, 2021, between Timothy Hannan and eHealth, Inc.
Annual Report on Form 10-K
(File No. 001-33071) February 26, 2021
10.8* Severance Agreement, dated September 19, 2021, between Christine Janof s k y and eHealth, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) November 8, 2021
10.9* Severance Agreement, dated as of February 8, 2021, between Phillip Morelock and eHealth, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) May 10, 2021
10.10 Investment Agreement, dated as of February 17, 2021, by and between eHealth, Inc. and Echelon Health SPV, LP
Current Report on Form 8-K (File No. 001-33071) February 18, 2021
10.11 Lease Agreement, dated March 29, 2018, between Ascentris-116b, LLC and eHealth, Inc.
Current Report on Form 8-K
(File No. 001-33071) April 2, 2018
10.12 Lease Agreement, dated April 25, 2018, between Augustine Bowers LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) April 30, 2018
10.12.1 First Amendment to Lease, dated August 19, 2019, between Augustine Bowers LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K (File No. 001-33071) August 21, 2019
10.13 Lease Agreement, dated May 2004, between eHealthInsurance Services, Inc. and Brian Avery, Trustee of the 1983 Avery Investments Trust, as amended
Registration Statement on Form S-l, as amended (File No. 333-133526) April 25, 2006
141
10.13.1 First Amendment to Lease Agreement, effective as of May 15, 2009, between eHealthInsurance Services, Inc. and Brian Avery, Trustee of the 1983 Avery Investments Trust
Current Report on Form 8‑K
(File No. 001-33071) May 21, 2009
10.13.2 Second Amendment to Lease Agreement, effective as of August 5, 2010 between eHealth Insurance Services, Inc. and Brian Avery, Trustee of the 1983 Avery Investments Trust
Current Report on Form 8‑K
(File No. 001-33071) August 18, 2010
10.13.3 Third Amendment to Lease Agreement, effective as of July 8, 2011, between eHealthInsurance Services, Inc. and Brian Avery, Trustee of the 1983 Avery Generations Trust
Current Report on Form 8-K
(File No. 001-33071) July 12, 2011
10.13.4 Fourth Amendment to Lease Agreement, effective as of July 13, 2018, between eHealthInsurance Services, Inc. and Brian Avery, Trustee of the 1983 Avery Investments Trust
Quarterly Report on Form 10-Q
(File No. 001-33071)
November 6, 2018
10.14 Standard Lease Agreement, dated June 10, 2004, between eHealthInsurance Services, Inc. and Gold Pointe E LLC, as amended
Registration Statement on
Form S-l, as amended
(File No. 333-133526) April 25, 2006
10.14.1 Fourth Amendment to Standard Lease Agreement (Office), effective as of November 6, 2007, between eHealthInsurance Services, Inc. and Carlsen Investments, LLC
Current Report on Form 8-K
(File No. 001-33071) November 7, 2007
10.14.2 Sixth Amendment to Lease and Acknowledgment to Standard Lease Agreement, dated August 29, 2012, between Carlsen Investments, LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) August 31, 2012
10.14.3 Seventh Amendment to Lease and Acknowledgment to Standard Lease Agreement, dated August 6, 2014, between Carlsen Investments, LLC and eHealthInsurance Services, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) August 8, 2014
10.14.4 Eighth Amendment to Standard Lease Agreement (Officer) and Partial Termination of Lease dated June 23, 2016 between Carlsen Investments, LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) June 28, 2016
10.14.5 Ninth Amendment to Lease and Acknowledgment to Standard Lease Agreement (Office) dated August 17, 2016 between Carlsen Investments, LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) August 22, 2016
10.14.6 Tenth Amendment to Lease and Acknowledgment to Standard Lease Agreement (Office) between Carlsen Investments, LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) April 12, 2019
10.14.7 Eleventh Amendment to Lease and Acknowledgment to Standard Lease Agreement (Office) between Carlsen Investments, LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) February 4, 2020
10.14.8 Twelfth Amendment to Lease and Acknowledgment to Standard Lease Agreement (Office), dated August 28, 2020, between Carlsen Investments, LLC and eHealthInsurance Services, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) November 5, 2020
10.15 Office Lease Contract, effective as of September 1, 2019, between eHealth China (Xiamen) Technology Co., Ltd and Xiamen Software Industry Investment & Development Co. Ltd.
Current Report on Form 8-K (File No. 001-33071) September 6, 2019
10.15.1 Property Management Service Contract, effective as of September 1, 2019, between eHealth China (Xiamen) Technology Co., Ltd and Xiamen Software Industry Investment & Development Co. Ltd.
Current Report on Form 8-K (File No. 001-33071) September 6, 2019
10.15.2 Office Lease Contract, effective as of September 15, 2019, between eHealth China (Xiamen) Technology Co., Ltd and Xiamen Software Industry Investment & Development Co. Ltd.
Current Report on Form 8-K (File No. 001-33071) September 6, 2019
10.15.3 Property Management Service Contract, effective as of September 15, 2019, between eHealth China (Xiamen) Technology Co., Ltd and Xiamen Software Industry Investment & Development Co. Ltd.
Current Report on Form 8-K (File No. 001-33071) September 6, 2019
10.16 Lease Agreement, dated March 23, 2012, between 340 Middlefield, LLC and eHealth, Inc.
Current Report on Form 8-K (File No. 001-33071) March 27, 2012
10.16.1 First Amendment to Lease Agreement, effective as of May 28, 2013, between 340 Middlefield, LLC and eHealth, Inc.
Current Report on Form 8-K (File No. 001-33071) May 29, 2013
10.16.2 Sublease, dated November 2, 2018, between JJ Lake Corporation and eHealth, Inc.
Current Report on Form 8-K (File No. 001-33071) November 30, 2018
10.16.3 Consent to Sublease, dated November 27, 2018, by and among 340 Middlefield, LLC, JJ Lake Corporation and eHealth, Inc.
Current Report on Form 8-K (File No. 001-33071) November 30, 2018
142
10.17 Office Lease, dated May 7, 2012, between Lake Pointe Three, LC, and eHealthInsurance Services, Inc.
Quarterly Report on Form 10-Q (File No. 001-33071) August 9, 2012
10.17.1 Subordination, Non-Disturbance and Attornment Agreement dated as September 14, 2016 by and among Deutsche Bank, AG, SLC Lake Pointe Equities LLC and eHealthInsurance Services, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) November 8, 2016
10.17.2 Amendment No. 1 to Lease, dated August 17, 2017, between SLC Lake Pointe SPE LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) August 22, 2017
10.17.3 Amendment No. 2 to Lease, dated December 12, 2017, between SLC Lake Pointe SPE LLC and eHealthInsurance Services, Inc.
Annual Report on Form 10-K (File No. 001-33071) March 19, 2018
10.17.4 Amendment No. 3 to Lease, dated March 20, 2019, between SLC Lake Pointe SPE LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) March 26, 2019
10.17.5 Amendment No. 4 to Lease, dated November 19, 2019, between SLC Lake Pointe SPE LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) November 19, 2019
10.18 Sublease Agreement, dated June 3, 2019, between Home Point Financial Corporation and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) June 7, 2019
10.18.1 Office Lease, dated June 3, 2019, between Precedent Lakeside Acquisitions, LLC and eHealthInsurance Services, Inc.
Current Report on Form 8-K
(File No. 001-33071) June 7, 2019
10.18.2 Consent to Sublease, dated June 3, 2019, between Home Point Financial Corporation, eHealthInsurance Services, Inc. and Precedent Lakeside Acquisitions, LLC.
Current Report on Form 8-K
(File No. 001-33071) June 7, 2019
10.19* Executive Bonus Plan
Quarterly Report on Form 10-Q
(File No. 001-33071) November 7, 2017
10.20* Amended and Restated 2014 Equity Incentive Plan
Current Report on Form 8-K
(File No. 001-33071) June 14, 2019
10.20.1* Form of Notice of Stock Option Grant and Stock Option Agreement under the 2014 Equity Incentive Plan of the Registrant
Registration Statement on
Form S-8 (File No. 333-196675) June 11, 2014
10.20.2* Form of Notice of Stock Unit Grant and Stock Unit Agreement under the 2014 Equity Incentive Plan of the Registrant
Registration Statement on
Form S-8 (File No. 333-196675) June 11, 2014
10.20.3* Form of Notice of Stock Unit Grant and Stock Unit Agreement (Initial Director Grant) under the 2014 Equity Incentive Plan of the Registrant
Registration Statement on
Form S-8 (File No. 333-196675) June 11, 2014
10.20.4* Form of Notice of Stock Unit Grant and Stock Unit Agreement (Annual Director Grant) under the 2014 Equity Incentive Plan of the Registrant
Registration Statement on
Form S-8 (File No. 333-196675) June 11, 2014
10.20.5 Form of Notice of Stock Option Grant and Stock Option Agreement (People’s Republic of China) under the 2014 Equity Incentive Plan of the Registrant
Registration Statement on
Form S-8 (File No. 333-196675) June 11, 2014
10.20.6 Form of Notice of Stock Unit Grant and Stock Unit Agreement (People’s Republic of China) under the 2014 Equity Incentive Plan of the Registrant
Registration Statement on
Form S-8 (File No. 333-196675) June 11, 2014
10.20.7* Form of Notice of Stock Unit Grant and Stock Unit Agreement (Performance-Based Vesting) under the 2014 Equity Incentive Plan of the Registration
Current Report on Form 8-K
(File No. 001-33071) March 23, 2015
10.20.8* Form of Notice of Stock Option Grant and Stock Option Agreement (Performance-Based Vesting) under the 2014 Equity Incentive Plan of eHealth, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) August 8, 2016
10.20.9* Form of Notice of Stock Unit Grant and Stock Unit Agreement (Performance-Based Vesting) under the 2014 Equity Incentive Plan of eHealth, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) August 8, 2016
143
10.20.10* Form of Stock Unit Grant and Stock Unit Agreement under the 2014 Equity Incentive Plan of eHealth, Inc.
Quarterly Report on Form 10-Q
(File No. 001-33071) August 6, 2021
10.21* Form of Deferral Election Form for Newly Eligible Individual with Existing Awards
Quarterly Report on Form 10-Q
(File No. 001-33071) November 6, 2015
10.21.1* Form of Deferral Election Form for Eligible Individual for Award to be Granted in the Next Calendar Year
Quarterly Report on Form 10-Q
(File No. 001-33071) November 6, 2015
10.22* 2020 Employee Stock Purchase Plan
Current Report on Form 8-K (File No. 001-33071) June 15, 2020
10.23* 2021 Inducement Plan
Current Report on Form 8-K (File No. 001-33071) September 23, 2021
10.23.1* Form of Notice of Stock Option Grant and Stock Option Agreement under the 2021 Inducement Plan
Current Report on Form 8-K (File No. 001-33071) September 23, 2021
10.23.2* Form of Notice of Stock Option Grant and Stock Option Agreement (Performance-Based Vesting) under the 2021 Inducement Plan
Current Report on Form 8-K (File No. 001-33071) September 23, 2021
10.23.3* Form of Notice of Stock Unit Grant and Stock Unit Agreement under the 2021 Inducement Plan
Current Report on Form 8-K (File No. 001-33071) September 23, 2021
10.23.4* Form of Notice of Stock Unit Grant and Stock Unit Agreement (Performance-Based) Vesting under the 2021 Inducement Plan
Current Report on Form 8-K (File No. 001-33071) September 23, 2021
21.1 List of Subsidiaries
Annual Report on Form 10-K (File No. 001-33071) March 19, 2018
23.1 † Consent of Independent Registered Public Accounting Firm
31.1 † Certification of Francis Soistman, Chief Executive Officer of eHealth, Inc., pursuant to Exchange Act Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 † Certification of Christine Janofsky, Chief Financial Officer of eHealth, Inc., pursuant to Exchange Act Rule 13a‑14(a) and 15d‑14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 ‡ Certification of Francis Soistman Chief Executive Officer of eHealth, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2 ‡ Certification of Christine Janofsky, Chief Financial Officer of eHealth, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS † Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH † Inline XBRL Taxonomy Extension Schema Document
101.CAL † Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF † Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB † Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE † Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 The cover page from the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, formatted in Inline XBRL and contained in Exhibit 101
† Filed herewith.
‡ Furnished herewith.
* Indicates a management contract or compensatory plan or arrangement.
144